News
12 April, 2025
Gender hormone reviewed
THE State Government has appointed one of Australia’s most respected psychiatrists to lead an independent review of Stage 1 and Stage 2 hormone therapies to treat children with gender dysphoria in Queensland.
Professor Ruth Vine will examine the evidence for using puberty suppression (Stage 1) and gender-affirming (Stage 2) hormone therapy for children with gender dysphoria in Queensland Health facilities.
The decision to conduct the independent and robust review was announced in January following the tightening of regulations around prescribing hormone therapy to children and adolescents in several European countries and the United Kingdom.
A final report will be submitted to Queensland Health Director-General Dr. David Rosengren by 30 November 2025.
Minister for Health and Ambulance Services, Tim Nicholls, said the review would ensure only the safest and most appropriate care was provided for young people experiencing gender dysphoria.
